
handle: 11570/3283729
Nowadays, scientific knowledge seems to be increasingly generated using technological methods, but also governed by technological demands and conducted by new technical ways of learning. In this paper I will analyze an effective example of this new trend in biomedical research: the Avicenna project and its “roadmap for clinical trials”. My aim is to understand what philosophical issues it arises and whether and to what extent this document provides effective responses and solutions to make its innovative challenges a concrete reality.
scientific knowledge, B1-5802, embodied subjectivity, Philosophy (General), in silico clinical trials
scientific knowledge, B1-5802, embodied subjectivity, Philosophy (General), in silico clinical trials
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
